For: |
Jia L, Zheng JJ, Jiang SM, Huang KH. Preparation, physicochemical characterization and cytotoxicity |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v16/i8/1008.htm |
Number | Citing Articles |
1 |
Katayoun Derakhshandeh, Sahar Fathi. Role of chitosan nanoparticles in the oral absorption of Gemcitabine. International Journal of Pharmaceutics 2012; 437(1-2): 172 doi: 10.1016/j.ijpharm.2012.08.008
|
2 |
Ozgur Esim, Cansel K. Ozkan, Meral Sarper, Ayhan Savaser, Yalcin Ozkan. Development of Gemcitabine Loaded PLGA/Lecithin Nanoparticles for Non-Small Cell Lung Cancer Therapy. Current Drug Delivery 2020; 17(7): 622 doi: 10.2174/1567201817666200512094145
|
3 |
Jianfeng Wang, Xiaomin Zhang, Yixin Cen, Xianfu Lin, Qi Wu. Antitumor gemcitabine conjugated micelles from amphiphilic comb-like random copolymers. Colloids and Surfaces B: Biointerfaces 2016; 146: 707 doi: 10.1016/j.colsurfb.2016.07.027
|
4 |
Abhishek Pandey. Nanoscience in Medicine Vol. 1. Environmental Chemistry for a Sustainable World 2020; 39: 249 doi: 10.1007/978-3-030-29207-2_8
|
5 |
Mohd Talha, Nishit Pathak, Sanjib Bhattacharyya, Yuanhua Lin. Applications of Multifunctional Nanomaterials. 2023; : 461 doi: 10.1016/B978-0-12-820557-0.00024-2
|
6 |
Shweta Paroha, Juhi Verma, Arvind K. Singh Chandel, Shalini Kumari, Laxmi Rani, Ravindra Dhar Dubey, Aman Kumar Mahto, Amulya K. Panda, Pravat Kumar Sahoo, Rikeshwer Prasad Dewangan. Augmented therapeutic efficacy of Gemcitabine conjugated self-assembled nanoparticles for cancer chemotherapy. Journal of Drug Delivery Science and Technology 2022; 76: 103796 doi: 10.1016/j.jddst.2022.103796
|
7 |
Catrin Strobel, Gerhard Schmidmaier, Britt Wildemann. Changing the Release Kinetics of Gentamicin from Poly(D, L-Lactide) Implant Coatings Using Only One Polymer. The International Journal of Artificial Organs 2011; 34(3): 304 doi: 10.5301/IJAO.2011.6470
|
8 |
Susan M. van Dommelen, Pieter Vader, Samira Lakhal, S.A.A. Kooijmans, Wouter W. van Solinge, Matthew J.A. Wood, Raymond M. Schiffelers. Microvesicles and exosomes: Opportunities for cell-derived membrane vesicles in drug delivery. Journal of Controlled Release 2012; 161(2): 635 doi: 10.1016/j.jconrel.2011.11.021
|
9 |
Lukas Neutsch, Michael Wambacher, Eva-Maria Wirth, Sylvia Spijker, Hanspeter Kählig, Michael Wirth, Franz Gabor. UPEC biomimickry at the urothelial barrier: Lectin-functionalized PLGA microparticles for improved intravesical chemotherapy. International Journal of Pharmaceutics 2013; 450(1-2): 163 doi: 10.1016/j.ijpharm.2013.04.058
|
10 |
Leela R. Jaidev, Laxmi S. Chede, Hemanth K. Kandikattu. Theranostic Nanoparticles for Pancreatic Cancer Treatment. Endocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21(2): 203 doi: 10.2174/1871530320666200516164911
|
11 |
Nalin Maniwongwichit, Rawita Morarad, Phimchanok Sakunpongpitiporn, Napa Parinyanitikul, Nophawan Paradee, Anuvat Sirivat. Magnetically controlled transdermal delivery of gemcitabine via xanthan gum-coated magnetic nanoparticles embedded in gellan gum cryogel. Materials Chemistry and Physics 2024; 326: 129836 doi: 10.1016/j.matchemphys.2024.129836
|
12 |
Rammohan Devulapally, Ramasamy Paulmurugan. Polymer nanoparticles for drug and small silencing RNA delivery to treat cancers of different phenotypes. WIREs Nanomedicine and Nanobiotechnology 2014; 6(1): 40 doi: 10.1002/wnan.1242
|
13 |
Ravindra Dhar Dubey, Noor Alam, Ankit Saneja, Vaibhav Khare, Ashok Kumar, Shagun Vaidh, Girish Mahajan, Parduman R. Sharma, Shashank K. Singh, Dilip M. Mondhe, Prem N. Gupta. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine. International Journal of Pharmaceutics 2015; 492(1-2): 80 doi: 10.1016/j.ijpharm.2015.07.012
|
14 |
Ravindra Dhar Dubey, Ankit Saneja, Prasoon K. Gupta, Prem N. Gupta. Recent advances in drug delivery strategies for improved therapeutic efficacy of gemcitabine. European Journal of Pharmaceutical Sciences 2016; 93: 147 doi: 10.1016/j.ejps.2016.08.021
|
15 |
Jithu Joseph. Applications of Nanovesicular Drug Delivery. 2022; : 267 doi: 10.1016/B978-0-323-91865-7.00011-0
|
16 |
L.R. Jaidev, Uma Maheswari Krishnan, Swaminathan Sethuraman. Gemcitabine loaded biodegradable PLGA nanospheres for in vitro pancreatic cancer therapy. Materials Science and Engineering: C 2015; 47: 40 doi: 10.1016/j.msec.2014.11.027
|
17 |
Sachin S. Surwase, Neha M. Munot, Bhaskar B. Idage, Susheela B. Idage. Tailoring the properties of mPEG-PLLA nanoparticles for better encapsulation and tuned release of the hydrophilic anticancer drug. Drug Delivery and Translational Research 2017; 7(3): 416 doi: 10.1007/s13346-017-0372-9
|
18 |
Ali Razzazan, Fatemeh Atyabi, Bahram Kazemi, Rassoul Dinarvand. In vivo drug delivery of gemcitabine with PEGylated single-walled carbon nanotubes. Materials Science and Engineering: C 2016; 62: 614 doi: 10.1016/j.msec.2016.01.076
|
19 |
Shalu Shukla, Vinay Pandit. Trojan Microparticles : A Composite Nanoparticle Delivery System. Current Drug Therapy 2024; 19(4): 413 doi: 10.2174/1574885518666230726142855
|
20 |
P. T. Nandini, R. C. Doijad, H. N. Shivakumar, P. M. Dandagi. Formulation and evaluation of gemcitabine-loaded solid lipid nanoparticles. Drug Delivery 2015; 22(5): 647 doi: 10.3109/10717544.2013.860502
|
21 |
Jayanta Bhattacharyya, Isaac Weitzhandler, Shihan Bryan Ho, Jonathan R. McDaniel, Xinghai Li, Lei Tang, Jinyao Liu, Mark Dewhirst, Ashutosh Chilkoti. Encapsulating a Hydrophilic Chemotherapeutic into Rod‐Like Nanoparticles of a Genetically Encoded Asymmetric Triblock Polypeptide Improves Its Efficacy. Advanced Functional Materials 2017; 27(12) doi: 10.1002/adfm.201605421
|
22 |
Yasmin Abo-zeid, Giuseppe Mantovani, William L. Irving, Martin C. Garnett. Synthesis of nucleoside-boronic esters hydrophobic pro-drugs: A possible route to improve hydrophilic nucleoside drug loading into polymer nanoparticles. Journal of Drug Delivery Science and Technology 2018; 46: 354 doi: 10.1016/j.jddst.2018.05.027
|
23 |
Christian Celia, Donato Cosco, Donatella Paolino, Massimo Fresta. Gemcitabine-loaded innovative nanocarriers vs GEMZAR: Biodistribution, pharmacokinetic features andin vivoantitumor activity. Expert Opinion on Drug Delivery 2011; 8(12): 1609 doi: 10.1517/17425247.2011.632630
|
24 |
Nicole J. Bassous, Thomas J. Webster. Racing for the Surface. 2020; : 357 doi: 10.1007/978-3-030-34475-7_16
|
25 |
Gebremariam Birhanu, Hamid Akbari Javar, Ehsan Seyedjafari, Ali Zandi-Karimi. Nanotechnology for delivery of gemcitabine to treat pancreatic cancer. Biomedicine & Pharmacotherapy 2017; 88: 635 doi: 10.1016/j.biopha.2017.01.071
|
26 |
Nimil Sood, Walter T. Jenkins, Xiang-Yang Yang, Nikesh N. Shah, Joshua S. Katz, Cameron J. Koch, Paul R. Frail, Michael J. Therien, Daniel A. Hammer, Sydney M. Evans. Biodegradable Polymersomes for the Delivery of Gemcitabine to Panc-1 Cells. Journal of Pharmaceutics 2013; 2013: 1 doi: 10.1155/2013/932797
|
27 |
Skyla A. Duncan, Saurabh Dixit, Rajnish Sahu, David Martin, Dieudonné R. Baganizi, Elijah Nyairo, Francois Villinger, Shree R. Singh, Vida A. Dennis. Prolonged Release and Functionality of Interleukin-10 Encapsulated within PLA-PEG Nanoparticles. Nanomaterials 2019; 9(8): 1074 doi: 10.3390/nano9081074
|